Condition Guide

Peptides for Growth Hormone Deficiency

Unlike exogenous human growth hormone, GHRH analogs and ghrelin receptor agonists stimulate the pituitary to release GH in pulsatile, physiological patterns while preserving negative feedback.

Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.

How peptides help

Sermorelin (GHRH 1-29), CJC-1295 (modified GHRH), ipamorelin (selective ghrelin agonist), and MK-677 (oral ghrelin agonist) all elevate endogenous GH and downstream IGF-1. Tesamorelin is FDA approved specifically for HIV-associated lipodystrophy.

Peptides researched for growth hormone deficiency

State of the evidence

Tesamorelin has FDA-approval-level evidence for its specific indication. Other GHRH/GHRP peptides have limited large-scale human data; off-label anti-aging use is common but not FDA-endorsed.

Frequently asked

Are GHRH peptides safer than HGH?

They preserve the body's negative feedback on GH secretion, theoretically reducing risk of supraphysiologic GH levels. However, head-to-head safety data vs. recombinant HGH is limited.

Related articles & guides

Related conditions